Return on investment of self-measured blood pressure is associated with its use in preventing false diagnoses, not monitoring hypertension.
Return on investment of self-measured blood pressure is associated with its use in preventing false diagnoses, not monitoring hypertension. PLoS One. 2021; 16(6):e0252701.